Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Yoshitaka Itami"'
Autor:
Akira Tachibana, Kota Iida, Yoshitaka Itami, Masaya Hashimura, Yukinari Hosokawa, Kiyohide Fujimoto
Publikováno v:
IJU Case Reports, Vol 6, Iss 5, Pp 278-281 (2023)
Introduction Composite pheochromocytoma is a rare tumor, occurring in only 3% of pheochromocytomas. We report a case of composite pheochromocytoma with neurofibromatosis type 1. Case presentation A 42‐year‐old man was referred to our department f
Externí odkaz:
https://doaj.org/article/4d688f1a00a745cfa7cb51029775dd03
Autor:
Makito Miyake, Satoshi Anai, Yusuke Iemura, Kazuki Ichikawa, Tatsuki Miyamoto, Atsushi Tomioka, Masaomi Kuwada, Yoshitaka Itami, Yukinari Hosokawa, Yoshiaki Matsumura, Eijiro Okajima, Kazumasa Torimoto, Nobutaka Nishimura, Mitsuru Tomizawa, Takuto Shimizu, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kiyohide Fujimoto
Publikováno v:
Methods and Protocols, Vol 7, Iss 4, p 58 (2024)
Unresectable, metastatic, advanced urothelial carcinoma (aUC) is an aggressive disease and is treated with platinum-containing first-line chemotherapy, followed by immune checkpoint inhibitors and antibody–drug conjugates. Response to first-line ch
Externí odkaz:
https://doaj.org/article/66cf9f04f1894534995c7d45255d6273
Autor:
Takuto Shimizu, Makito Miyake, Nobutaka Nishimura, Takanori Yoshida, Yoshitaka Itami, Akira Tachibana, Chihiro Omori, Yuki Oda, Mikiko Kohashi, Mitsuru Tomizawa, Kenta Onishi, Shunta Hori, Yosuke Morizawa, Daisuke Dotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Cancers, Vol 16, Iss 4, p 841 (2024)
Complete metastasectomy (CM) in metastatic renal cell carcinoma (mRCC) has demonstrated efficacy in the cytokine era, but its effectiveness in the era of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) remains unclear. A mul
Externí odkaz:
https://doaj.org/article/450a3274d3d14010932a4d42316fcbb6
Autor:
Yoshitaka Itami, Makito Miyake, Takuya Owari, Takashi Iwamoto, Daisuke Gotoh, Hitoshi Momose, Kiyohide Fujimoto, Shuya Hirao
Publikováno v:
BMC Urology, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background A history of preoperative obstructive pyelonephritis has been reported as a risk factor for febrile urinary tract infection (fUTI) after ureteroscopic lithotripsy (URSL). But there is no clear evidence of risk factors for developi
Externí odkaz:
https://doaj.org/article/d28e6c53c80d41eb9c6c0b443c1c3de1
Autor:
Daisuke Gotoh, Katsuya Aoki, Yosuke Morizawa, Shunta Hori, Yoshitaka Itami, Makito Miyake, Kazumasa Torimoto, Hitoshi Momose, Kiyohide Fujimoto
Publikováno v:
IJU Case Reports, Vol 3, Iss 3, Pp 90-92 (2020)
Introduction Spina bifida is a congenital anomaly caused by a neural tube closure defect that may result in sexual dysfunction. Sexual dysfunction and infertility are prevalent in spina bifida patients but have been scarcely reported. Case presentati
Externí odkaz:
https://doaj.org/article/439904051fa54a1ea3f713bb69a23089
Autor:
Makito Miyake, Shinji Fukui, Daisuke Gotoh, Yoshiaki Matsumura, Shoji Samma, Yoshihiro Matsumoto, Hitoshi Momose, Shunta Hori, Shuji Watanabe, Takuya Owari, Yosuke Morizawa, Yoshitaka Itami, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-8 (2019)
Abstract Background Retroperitoneal tumors are an uncommon disease known to consist of a diverse group of benign and malignant neoplasms. Treatment of unresectable retroperitoneal lesions requires pathological diagnosis. Here, we report the utility a
Externí odkaz:
https://doaj.org/article/daadcadb382e40f29ebbe966315ae1bc
Autor:
Takuya Owari, Makito Miyake, Yasushi Nakai, Nobumichi Tanaka, Yoshitaka Itami, Shuya Hirao, Hitoshi Momose, Yoshinori Nakagawa, Kouta Iida, Fumisato Maesaka, Takuto Shimizu, Yusuke Iemura, Yoshihiro Matsumoto, Masaomi Kuwada, Takeshi Otani, Kenji Otsuka, Eijiro Okajima, Yukinari Hosokawa, Ryosuke Okamura, Kiyohide Fujimoto
Publikováno v:
Journal of Bone Oncology, Vol 26, Iss , Pp 100344- (2021)
Objective: We previously developed genitourinary (GU) cancer-specific scoring system for prediction of survival in patients with bone metastasis (the Bone-Fujimoto-Owari-Miyake [B-FOM] scoring model) based on five prognostic factors: the type of prim
Externí odkaz:
https://doaj.org/article/c74aa3e244c64d51bd2395cd81432b31
Autor:
Makito Miyake, Shunta Hori, Yoshitaka Itami, Yuki Oda, Takuya Owari, Tomomi Fujii, Sayuri Ohnishi, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Satoshi Anai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Cancers, Vol 12, Iss 7, p 1942 (2020)
Chemotherapy-induced adverse effects can reduce the relative dose intensity and quality of life. In this study, we investigated the potential benefit of supplementary anamorelin and 5-aminolevulinic acid (5-ALA) as preventive interventions against a
Externí odkaz:
https://doaj.org/article/1a7eb8df78c9499fa0a6ba48ca03023f
Autor:
Takuto Shimizu, Makito Miyake, Shunta Hori, Kazuki Ichikawa, Chihiro Omori, Yusuke Iemura, Takuya Owari, Yoshitaka Itami, Yasushi Nakai, Satoshi Anai, Atsushi Tomioka, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Diagnostics, Vol 10, Iss 5, p 310 (2020)
Sarcopenia is a muscle loss syndrome known as a risk factor of various carcinomas. The impact of sarcopenia and sarcopenia-related inflammatory/nutritional markers in metastatic urothelial carcinoma (mUC) treated with pembrolizumab was unknown, so th
Externí odkaz:
https://doaj.org/article/965726a99e084eafb01692f1bcba14c2
Autor:
Yoshitaka Itami, Makito Miyake, Sayuri Ohnishi, Yoshihiro Tatsumi, Daisuke Gotoh, Shunta Hori, Yousuke Morizawa, Kota Iida, Kenta Ohnishi, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Nobumichi Tanaka, Tomomi Fujii, Keiji Shimada, Hideki Furuya, Vedbar S. Khadka, Youping Deng, Kiyohide Fujimoto
Publikováno v:
Diagnostics, Vol 10, Iss 1, p 54 (2020)
Disabled homolog-2 (DAB2) has been reported to be a tumor suppressor gene. However, a number of contrary studies suggested that DAB2 promotes tumor invasion in urothelial carcinoma of the bladder (UCB). Here, we investigated the clinical role and bio
Externí odkaz:
https://doaj.org/article/9757750df7914f3a884f1cf4057ee536